Commentary

CORE Industrial expands 3D printing empire, Peak Rock snags Paragon Healthcare, GI Partners closes debut digital infrastructure fund on $1.8bn

Peak Rock is buying Paragon Healthcare and GI racks up $1.8 billion for initial digital infrastructure fund.

How private practice plus private equity can help balance an unbalanced system

When structured and executed correctly, private equity can be a powerful vehicle for change at a time when change is what the healthcare system needs.

Welsh, Carson, Anderson & Stowe taps Goldman, Credit Suisse to explore options for Clearwater Analytics, Alcentra recruits ex-Bain Capital Credit exec as CEO, Private equity bets on powerful Democrat in key role on carried interest tax

WCAS is mulling options for Clearwater Analytics and Alcentra hires former Bain Capital Credit executive Jonathan DeSimone as CEO.

Pharma services shows its covid-resistancy: GHO, Blackstone, Kohlberg ride the tailwinds and Webster Equity Partners is officially in the market with Fund V.

GHO Capital agrees to buy Ardian’s stake in UK's Envision Pharma Group.

TCV buys majority stake in Oversight from Luminate Capital, GHO to buy out Ardian's stake in Envision Pharma, Audax Group runs broad secondary recap on 2012 fund

GHO Capital agreed to buy out Ardian's stake in Envision Pharma Group and secondaries are poised for a busy fall.

KKR to generate 25 pct IRR on Epicor, AlpInvest leads Kinderhook Fund III recapitalization, Webster Equity targets $1bn for first healthcare-only fund

The tech M&A market is picking up in volume and Webster Equity is seeking to raise $1 billion for its inaugural healthcare-focused fund.

Roark backs US Sports Camps, Advent's Sovos adds a breakfast brand to its basket, LACERS discusses shift in secondaries strategy

Advent acquires Birch Benders as an add-on for Sovos Brand and Roark Capital invests in US Sports Camps, a youth sports camp company.

Cryoport shares rally following Blackstone's bet on cell and gene therapy; Dyal's latest GP stakes fund expected to surpass $5bn target; Levine Leichtman buys Bridgepoint Development's BigHand

Blackstone invests in Cryoport causing the latter's stock to soar and Levine Leichtman acquires BigHand from Bridgepoint Development.

Consolidators brace for decision on California's controversial SB 977; Kohlberg makes big splash for Partners' PCI Pharma

Blackstone Tactical Opportunities will be investing $275 million in Cryoport to support two new acquisitions in the cell and gene therapy supply chain.

JC Penney's sales under a magnifying glass; StoneBridge Healthcare bids for Erlanger Health System; New growth equity firm Venn Growth beefs up team

Erlanger Health System rebuffs StoneBridge's $425 million bid to acquire Erlanger Health Systems and Venn Growth expands its team while preparing to roll out a $300 million inaugural fund.